Dudediligence.

Atossa Therapeutics, Inc

ATOSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$7.2MSep ’24−$6.3MDec ’24−$6.7MMar ’25−$8.4MJun ’25−$8.7MSep ’25−$10.9MDec ’25−$9.6MMar ’26−$8.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$20.5M−$27.7M−$31.4M−$27.6M−$37.1M
Net income−$20.6M−$27.0M−$30.1M−$25.5M−$34.8M
Operating cash flow−$16.5M−$20.8M−$20.9M−$21.0M−$29.8M
Free cash flow−$16.5M−$20.8M−$21.0M−$21.0M−$29.8M
Cash$136.4M$110.9M$88.5M$71.1M$41.3M
Shares outstanding126.6M126.6M125.3M8.6M8.6M